title: [Vaccines and preventive activities in patients with inflammatory arthritis].
abstract: Patients with inflammatory arthritis and eligible for immunosuppressive therapy account for more than 1% of general population, and represents a significant workload on family doctors. They are prone to other comorbidities, with an increased cardiovascular risk and a higher incidence of infections than the general population, especially skin infections and pneumonitis. This comorbidity can be considered vulnerable to a prevention program-prevention of cardiovascular risk, cancer screening, vaccination schedule for adults. As for prevention through vaccination, importance should be given to pneumococcal infection - significant in adults aged 50 or over, especially amongst immunosuppressed patients. The 13-valent conjugate vaccine, which has been recently approved for adults, must be considered. An attempt has been made to write a simple, applicable document on preventive measures that should be implemented both at primary and secondary care level for those adults.
authors.affiliation: Sección de Reumatología, Hospital Clínico Virgen de la Victoria, Málaga, España. Electronic address: casalssanchez@gmail.com.
authors.forename: J L
authors.initials: JL
authors.lastname: Casals-Sánchez
authors.forename: C
authors.initials: C
authors.lastname: Casals Vázquez
authors.forename: M Á
authors.initials: MÁ
authors.lastname: Vázquez Sánchez
authors.forename: S
authors.initials: S
authors.lastname: Giménez Basallote
mesh_terms: D001168:Arthritis; D002318:Cardiovascular Diseases; D006801:Humans; D011008:Pneumococcal Infections / Q000517:prevention & control; D022242:Pneumococcal Vaccines; D012307:Risk Factors; D013296:Streptococcus pneumoniae; D014611:Vaccination
chemical_list: D022242:Pneumococcal Vaccines
keywords: Arthritis; Artritis; Factores de riesgo; Immunization programs; Prevención primaria; Primary prevention; Programas de inmunización; Risk factors; Vaccines; Vacunas